ID   J3T-BG/TMZ
AC   CVCL_D2PR
DR   Wikidata; Q127382398
RX   PubMed=37365849;
CC   Selected for resistance to: ChEBI; CHEBI_72564; Temozolomide (TMZ).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D2PM ! J3T-Bg
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=37365849; DOI=10.1002/vms3.1181; PMCID=PMC10357258;
RA   Fuchs D., Rohrer Bley C., Morandi L., Tonon C., Weyland M.S.,
RA   Nytko-Karouzakis K.J.;
RT   "Triple combination of lomustine, temozolomide and irradiation reduces
RT   canine glioma cell survival in vitro.";
RL   Vet. Med. Sci. 9:1573-1583(2023).
//